000 01026 a2200289 4500
005 20250514150637.0
264 0 _c20030501
008 200305s 0 0 eng d
022 _a0022-2143
040 _aNLM
_beng
_cNLM
100 1 _aPAYNE, R W
245 0 0 _aThe value of phenylbutazone in the treatment of rheumatoid arthritis as determined by clinical response and by the serum protein-polysaccharide ratio (PR).
_h[electronic resource]
260 _bThe Journal of laboratory and clinical medicine
_cMar 1955
300 _a331-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnalgesics
_xtherapeutic use
650 0 4 _aArthritis
650 0 4 _aArthritis, Rheumatoid
_xtherapy
650 0 4 _aBlood Proteins
650 0 4 _aPhenylbutazone
650 0 4 _aPolysaccharides
_xblood
700 1 _aSHETLAR, M R
700 1 _aFARR, C H
700 1 _aHELLBAUM, A A
700 1 _aISHMAEL, W K
773 0 _tThe Journal of laboratory and clinical medicine
_gvol. 45
_gno. 3
_gp. 331-9
999 _c14116131
_d14116131